Back to Market Feed

Product Information

KETAMINE 500 MG/5 ML VIAL is a generic product labeled by Fresenius Kabi USA, LLC, priced at $1.5436 per ML under NDC 65219018605. Its NADAC has been published 40 times since Nov 19, 2025.

FDA first approved this application on Jan 13, 2023. Its Orange Book therapeutic-equivalence code is AP.

KETAMINE 500 MG/5 ML VIAL

ketamine hydrochloride
$1.5436per ML
DEA Schedule CIII

Strength

100 mg/mL

NDC

65219018605

Classification

Generic

Dosage Form

INJECTION

Route

INTRAMUSCULAR; INTRAVENOUS

Effective Date

8/19/2026

Active Ingredients

KETAMINE HYDROCHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA215808

FDA Approved

1/13/2023

TE Code

AP

On Market Since

7/10/2023

Pharmacological Classes

General Anesthesia
General Anesthetic

Price Statistics

The NADAC for KETAMINE 500 MG/5 ML VIAL has been published 40 times since Nov 19, 2025, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.

Current price$1.5436 per ML
All-time high$1.5655 (May 13, 2026)
All-time low$1.5436 (Jul 22, 2026)
52-week high$1.5655
52-week low$1.5436
Median price$1.5599
Average price$1.5580
Largest weekly change-0.6% (Jun 17, 2026)
Weeks tracked40
Tracking sinceNov 19, 2025

Price History

1W

0.0%

1M

0.0%

3M

-1.0%

6M

-1.0%

1Y

N/A

3Y

N/A

5Y

N/A

All

-1.2%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the ketamine hydrochloride market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Related Drugs

Same classification

PROPOFOL 200 MG/20 ML VIAL
Generic
00409601025•Hospira Inc.
$0.1709
per ML
PROPOFOL 200 MG/20 ML VIAL
Generic
25021060820•Sagent Pharmaceuticals
$0.1709
per ML
PROPOFOL 200 MG/20 ML VIAL
Generic
43598026525•Dr. Reddy's Laboratories Inc.
$0.1709
per ML
KETAMINE 500 MG/10 ML VIAL
Generic
00143950810•Hikma Pharmaceuticals USA Inc.
$0.5579
per ML
KETAMINE 500 MG/10 ML VIAL
Generic
00409205310•Hospira Inc.
$0.5579
per ML
KETAMINE 500 MG/10 ML VIAL
Generic
25021068310•Sagent Pharmaceuticals
$0.5579
per ML
KETAMINE 500 MG/10 ML VIAL
Generic
55150043910•Eugia US LLC
$0.5579
per ML
KETAMINE 500 MG/10 ML VIAL
Generic
72572032010•Civica, Inc.
$0.5579
per ML
KETAMINE 500 MG/5 ML VIAL
Generic
00143950910•Hikma Pharmaceuticals USA Inc.
$1.5436
per ML
KETAMINE 500 MG/5 ML VIAL
Generic
00409004010•Hospira Inc.
$1.5436
per ML

Frequently asked questions

What is the NADAC price of KETAMINE 500 MG/5 ML VIAL?

The current National Average Drug Acquisition Cost (NADAC) for KETAMINE 500 MG/5 ML VIAL, manufactured by Fresenius Kabi USA, LLC, is $1.5436 per ML (NDC 65219018605), effective Aug 19, 2026.

How has the price of KETAMINE 500 MG/5 ML VIAL changed over time?

Over the history we have for it, the NADAC for KETAMINE 500 MG/5 ML VIAL has held within roughly two percent of its current level. It has been tracked across 40 weekly CMS publications since Nov 19, 2025.

What are the highest and lowest recorded NADAC prices for KETAMINE 500 MG/5 ML VIAL?

Since Nov 19, 2025, the NADAC for KETAMINE 500 MG/5 ML VIAL has ranged from a low of $1.5436 (Jul 22, 2026) to a high of $1.5655 (May 13, 2026), with a median of $1.5599 per ML.

Are there cheaper alternatives to KETAMINE 500 MG/5 ML VIAL?

No other NADAC-published product currently shares the active ingredient and strength of KETAMINE 500 MG/5 ML VIAL in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures KETAMINE 500 MG/5 ML VIAL?

KETAMINE 500 MG/5 ML VIAL (NDC 65219018605) is labeled by Fresenius Kabi USA, LLC, and CMS classifies it as a generic product.